The Sacral Nerve Stimulation Market is expected to register a CAGR of 5.5% during the forecast period. This is attributing to the rising prevalence of overactive bladder conditions and increasing incidence of urge incontinence such as Urinary tract infection (UTI). In addition, growing incidences of fecal incontinence and the availability of medical reimbursements are some more factors fueling market growth. As per the article published in the Indian Journal of Community Medicine 2019, the study reported that the prevalence of urinary incontinence in post-menopausal women age 45-90 is around 26.47 %. In addition, urinary incontinence has a huge impact on social and mental health. The sacral nerve stimulation will help in enhancing the quality of life of the affected population. Moreover, as per the Center for Medicare and Medicaid Services (CMS) an estimate of around 13 million population are affected by urinary incontinence and most of them are women. Thus, growing incidences of the target patient pool will surge demand for treatment and promote the sacral nerve stimulation market in the coming years. Furthermore, the rising geriatric population globally, growing research investments, and technological advancements associated with pharmaceuticals and medical devices are driving the sacral nerve stimulation market.

Key Market Trends

Sacral Nerve Stimulation in Urinary & Fecal Incontinence is Estimated to Witness a Healthy Growth in Future.

Sacral nerve stimulation in urinary & fecal incontinence is estimated to witness a healthy growth in the future attributed to the growing prevalence of patients suffering urinary tract infection (UTI), anal sphincter injuries and overactive bladder. As per the Global Health Data Exchange in 2017 an estimate of around 38 million population are affected by urinary tract infection. These populations will create a demand for treatment and thus drive the segment growth. Moreover, the rising number of populations suffering from constipation and pelvic pain is also anticipated to boost the segment growth.

In addition, the increasing biopharmaceutical R&D expenditure in the United States is expected to boost the growth of the sacral nerve stimulation market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the global Sacral Nerve Stimulation Market due to the rising prevalence of overactive bladder conditions (OAB) and urge incontinences, growing awareness about the availability of treatment and increasing adoption of technologically advanced medical devices such as implantable SNS device. Furthermore, well-established infrastructure, growing healthcare expenditure, and favorable reimbursement policies for innovation in devices and treatment procedures are some more factors that expected to fuel the Sacral Nerve Stimulation Market in this region.

Competitive Landscape

The Sacral Nerve Stimulation Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Nuvectra, Medtronic, NeuroPace, Inc., Laborie, Inc, Axonics Modulation Technologies, Inc., Nevro Corp., Boston Scientific Corporation, Synapse Biomedical Inc., and St. Jude Medical, Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support